[PDF][PDF] Statistical methods in cancer research
NE Breslow, NE Day, E Heseltine - 1980 - publications.iarc.fr
Twenty years have elapsed since Mantel and Haenszel published their seminal article on
statistical aspects of the analysis of data from case-control studies. Their methodology has …
statistical aspects of the analysis of data from case-control studies. Their methodology has …
Estimation of failure probabilities in the presence of competing risks: new representations of old estimators
TA Gooley, W Leisenring, J Crowley… - Statistics in …, 1999 - Wiley Online Library
A topic that has received attention in both the statistical and medical literature is the
estimation of the probability of failure for endpoints that are subject to competing risks …
estimation of the probability of failure for endpoints that are subject to competing risks …
Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study
Purpose Although patients with SARS-CoV-2 infection have several risk factors for ventilator-
associated lower respiratory tract infections (VA-LRTI), the reported incidence of hospital …
associated lower respiratory tract infections (VA-LRTI), the reported incidence of hospital …
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non …
Background Patients with human papillomavirus (HPV)-positive oropharyngeal squamous
cell carcinoma have high survival when treated with radiotherapy plus cisplatin. Whether …
cell carcinoma have high survival when treated with radiotherapy plus cisplatin. Whether …
Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non–Small Cell Lung Cancer
Purpose: Patients with KRAS-mutant non–small cell lung cancer (NSCLC) with brain
metastases (BM) have a poor prognosis. Adagrasib (MRTX849), a potent oral small …
metastases (BM) have a poor prognosis. Adagrasib (MRTX849), a potent oral small …
Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study
Background Mineralocorticoid receptor (MR) antagonists are the recommended medical
therapy for primary aldosteronism. Whether this recommendation effectively reduces …
therapy for primary aldosteronism. Whether this recommendation effectively reduces …
Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer
Purpose Conventional radiotherapy (C-RT) treatment schedules for patients with prostate
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
[ΒΙΒΛΙΟ][B] Análise de sobrevivência aplicada
EA Colosimo, SR Giolo - 2021 - books.google.com
Neste livro são apresentados conceitos básicos, técnicas não-paramétricas e os principais
modelos probabilísticos e de regressão utilizados na análise de dados de sobrevivência …
modelos probabilísticos e de regressão utilizados na análise de dados de sobrevivência …
[HTML][HTML] Somatic mutations of calreticulin in myeloproliferative neoplasms
T Klampfl, H Gisslinger, AS Harutyunyan… - … England Journal of …, 2013 - Mass Medical Soc
Background Approximately 50 to 60% of patients with essential thrombocythemia or primary
myelofibrosis carry a mutation in the Janus kinase 2 gene (JAK2), and an additional 5 to …
myelofibrosis carry a mutation in the Janus kinase 2 gene (JAK2), and an additional 5 to …
[HTML][HTML] First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE …
Background Data suggest selective internal radiotherapy (SIRT) in third-line or subsequent
therapy for metastatic colorectal cancer has clinical benefit in patients with colorectal liver …
therapy for metastatic colorectal cancer has clinical benefit in patients with colorectal liver …